AlphaGrep UK’s Lam Research LRCX Stock Holding History

AlphaGrep UK’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,697	Closed	-$363K	–	855
2026 Q1	$363K	Buy	+1,697	New	+$379K	0.1%	422

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

AlphaGrep UK's LRCX Position: Q2 2026 in Review

AlphaGrep UK sold out of Lam Research (LRCX) in Q2 2026, closing a stake of 1,697 shares — an estimated $363K sold.

AlphaGrep UK first reported a position in LRCX in Q1 2026 and held it in 1 quarter. The position peaked at $363K in Q1 2026. 2,991 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

AlphaGrep UK reported no remaining Lam Research position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 1,697 Lam Research shares in Q2 2026, an estimated $363K.
AlphaGrep UK first reported a position in Lam Research in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Lam Research position peaked at $363K in Q1 2026.
2,991 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.